The Association of Biotechnology Companies BioForum launches the #polishbiotech online database as the largest association of biotech companies in Poland.
We are the first point of contact for entrepreneurs in the biotechnology industry and we constantly support the Polish biotechnology community 👩🔬 👨🔬
SIGN UP HERE 👇👇👇
"*" indicates required fields
Bioceltix
+ business areaBioPharma R&D+Services
+ annual revenue
2019 - 2,000 PLN
2020 - 11,000 PLN
2021 - 0 PLN
2022 - 0 PLN
2023 - 0 PLN
2024 - 0 PLN
+ workforce (estimated if not reported)
2022 - 20
2023 - 28
2024 - 36
+ depreciation & amortization
2019 - 48,000 PLN
2020 - 89,000 PLN
2021 - 377,000 PLN
2022 - 445,000 PLN
2023 - 435,000 PLN
2024 - 574,000 PLN
A pioneering team develops innovative veterinary therapies using the immunomodulatory properties of mesenchymal stem cells (MSC). They adhere to the highest quality standards, including cGMP, enabling scalable, off-the-shelf production of cell-based medicines. Clinical trials under Good Clinical Practice (GCP) and collaboration with regulatory authorities ensure safety and efficacy, paving the way for groundbreaking solutions in veterinary medicine.